Published on October 9, 2009 at 8:20 AM
HTDS www.htdsmedical.com (HTDS) - The issuer's China based operating subsidiary Mellow Hope www.mellowhope.com is pleased to announce the clinical protocol is in the process of being approved. It is known that the Hepatitis A will be included in the Expanded Programme on Immunization (EPI) in 2010. Simply put, this means the market will cover all the new-born children. Mellow Hope expects its Mevac-A registration will be approved within the next 60-90 days.
The issuers Serbian based Slavica Bio Chem www.slavicabiochem.com brings attention to its Mindup Bioreseach cancer project conducted by molecular biologists and medical doctors: Sabera Ruzdijic, PhD as chief scientist, with Milica Pesic PhD, Tijana Andjelkovic MSc, Jasna Bankovic MD, PhD, Vedrana Milinkovic BSc, Ana Podolski BSc and Nikola Tanic PhD. The MindUp group is associated with the Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic", University of Belgrade. One of the posters showing current results of MindUp group will be filed with Pink Sheets today.
In other company news HTDS representatives are meeting with the Canadian Pharmaceutical company for the associate operation of the Mindup Bioresearch cancer project. The company's focus is entirely upon completing its audit and continuing its aspirations to merge with an already listed OTCBB company which HTDS has identified, and talks are well under way.
SOURCE Hard to Treat Diseases